Schedule 5 (V) Drugs
The drug has a low potential for abuse relative to the drugs in schedule 4. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.
The following drugs are listed as Schedule 5 (V) Drugs* by the Controlled Substances Act (CSA):
| Drug name | View by: Brand | Generic |
|---|---|
| atropine/diphenoxylate (Pro) | |
| brivaracetam (Pro) | |
| brompheniramine/codeine | |
| brompheniramine/codeine/phenylephrine | |
| brompheniramine/codeine/pseudoephedrine | |
| brompheniramine/dihydrocodeine/phenylephrine | |
| cenobamate (Pro) | |
| chlorpheniramine/codeine/phenylephrine | |
| chlorpheniramine/codeine/pseudoephedrine | |
| codeine/diphenhydramine/phenylephrine | |
| codeine/phenylephrine/promethazine (Pro) | |
| codeine/phenylephrine/triprolidine | |
| codeine/promethazine (Pro) | |
| codeine/pyrilamine | |
| ganaxolone (Pro) | |
| lacosamide (Pro) | |
| lasmiditan (Pro) | |
| pregabalin (Pro) | |
The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.